138 related articles for article (PubMed ID: 9144489)
21. A cis-acting element in the BCL-2 gene controls expression through translational mechanisms.
Harigai M; Miyashita T; Hanada M; Reed JC
Oncogene; 1996 Mar; 12(6):1369-74. PubMed ID: 8649841
[TBL] [Abstract][Full Text] [Related]
22. Genomic organization and expression of the mouse equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporter 1 (ENT1) gene.
Choi DS; Handa M; Young H; Gordon AS; Diamond I; Messing RO
Biochem Biophys Res Commun; 2000 Oct; 277(1):200-8. PubMed ID: 11027664
[TBL] [Abstract][Full Text] [Related]
23. Genomic organization of the mouse Msh4 gene producing bicistronic, chimeric and antisense mRNA.
Hirano M; Noda T
Gene; 2004 Nov; 342(1):165-77. PubMed ID: 15527976
[TBL] [Abstract][Full Text] [Related]
24. The gonadotropin-regulated long-chain acyl CoA synthetase gene: a novel downstream Sp1/Sp3 binding element critical for transcriptional promoter activity.
Sheng Y; Li J; Dufau ML; Tsai-Morris CH
Gene; 2005 Oct; 360(1):20-6. PubMed ID: 16125341
[TBL] [Abstract][Full Text] [Related]
25. Fli-1b is generated by usage of differential splicing and alternative promoter.
Dhulipala PD; Lee L; Rao VN; Reddy ES
Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
[TBL] [Abstract][Full Text] [Related]
26. Characterization of novel promoter and enhancer elements of the mouse homologue of the Dent disease gene, CLCN5, implicated in X-linked hereditary nephrolithiasis.
Tanaka K; Fisher SE; Craig IW
Genomics; 1999 Jun; 58(3):281-92. PubMed ID: 10373326
[TBL] [Abstract][Full Text] [Related]
27. Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter.
Hansen JJ; Bross P; Westergaard M; Nielsen MN; Eiberg H; Børglum AD; Mogensen J; Kristiansen K; Bolund L; Gregersen N
Hum Genet; 2003 Jan; 112(1):71-7. PubMed ID: 12483302
[TBL] [Abstract][Full Text] [Related]
28. Multiple transcription initiation sites, alternative splicing, and differential polyadenylation contribute to the complexity of human neurofibromatosis 2 transcripts.
Chang LS; Akhmametyeva EM; Wu Y; Zhu L; Welling DB
Genomics; 2002 Jan; 79(1):63-76. PubMed ID: 11827459
[TBL] [Abstract][Full Text] [Related]
29. Genomic cloning and characterization of the rat glutathione S-transferase-A3-subunit gene.
Fotouhi-Ardakani N; Batist G
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):685-93. PubMed ID: 10215608
[TBL] [Abstract][Full Text] [Related]
30. Organization and analysis of the promoter region and 5' non-coding exons of the human c-src proto-oncogene.
Bonham K; Fujita DJ
Oncogene; 1993 Jul; 8(7):1973-81. PubMed ID: 8510939
[TBL] [Abstract][Full Text] [Related]
31. Cloning and functional analysis of the mouse c-kit promoter.
Yasuda H; Galli SJ; Geissler EN
Biochem Biophys Res Commun; 1993 Mar; 191(3):893-901. PubMed ID: 7682073
[TBL] [Abstract][Full Text] [Related]
32. Four murine c-abl mRNAs arise by usage of two transcriptional promoters and alternative splicing.
Bernards A; Paskind M; Baltimore D
Oncogene; 1988 Apr; 2(4):297-304. PubMed ID: 3283651
[TBL] [Abstract][Full Text] [Related]
33. bcl-w, a novel member of the bcl-2 family, promotes cell survival.
Gibson L; Holmgreen SP; Huang DC; Bernard O; Copeland NG; Jenkins NA; Sutherland GR; Baker E; Adams JM; Cory S
Oncogene; 1996 Aug; 13(4):665-75. PubMed ID: 8761287
[TBL] [Abstract][Full Text] [Related]
34. Genomic structure and chromosomal localization of the mouse CDEI-binding protein CDEBP (APLP2) gene and promoter sequences.
Yang Y; Martin L; Cuzin F; Mattei MG; Rassoulzadegan M
Genomics; 1996 Jul; 35(1):24-9. PubMed ID: 8661100
[TBL] [Abstract][Full Text] [Related]
35. A complete description of the EGF-receptor exon structure: implication in oncogenic activation and domain evolution.
Callaghan T; Antczak M; Flickinger T; Raines M; Myers M; Kung HJ
Oncogene; 1993 Nov; 8(11):2939-48. PubMed ID: 8414496
[TBL] [Abstract][Full Text] [Related]
36. Mouse bcl-3: cDNA structure, mapping and stage-dependent expression in B lymphocytes.
Bhatia K; Huppi K; McKeithan T; Siwarski D; Mushinski JF; Magrath I
Oncogene; 1991 Sep; 6(9):1569-73. PubMed ID: 1923524
[TBL] [Abstract][Full Text] [Related]
37. Presence of the long and the short forms of Bcl-X in several human and murine tissues.
Rouayrenc JF; Boise LH; Thompson CB; Privat A; Patey G
C R Acad Sci III; 1995 May; 318(5):537-40. PubMed ID: 7670999
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the 5' untranslated region of the human c-fgr gene and identification of the major myelomonocytic c-fgr promoter.
Link DC; Gutkind SJ; Robbins KC; Ley TJ
Oncogene; 1992 May; 7(5):877-84. PubMed ID: 1373875
[TBL] [Abstract][Full Text] [Related]
39. Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene.
Pecci A; Viegas LR; Baranao JL; Beato M
J Biol Chem; 2001 Jun; 276(24):21062-9. PubMed ID: 11274164
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the complete genomic structure of the human WNT-5A gene, functional analysis of its promoter, chromosomal mapping, and expression in early human embryogenesis.
Danielson KG; Pillarisetti J; Cohen IR; Sholehvar B; Huebner K; Ng LJ; Nicholls JM; Cheah KS; Iozzo RV
J Biol Chem; 1995 Dec; 270(52):31225-34. PubMed ID: 8537388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
